CopyMark Law Group
4.9/5
Drawing for KITERA

USPTO serial 75587488

KITERA

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
RIRIE, VERNA BETH
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KITERA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Trademark Monitoring
(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jacqueline M. Stelling

JACQUELINE M STELLING KIRKPATRICK & LOCKHART LLP599 LEXINGTON AVENEW YORK, NY 10022UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of respiratory diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 1, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 1, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 8, 2005EX5GSOU EXTENSION 5 GRANTED—
May 24, 2005EXT5SOU EXTENSION 5 FILED—
May 24, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 5, 2005EX4GSOU EXTENSION 4 GRANTED—
Dec 21, 2004EXT4SOU EXTENSION 4 FILED—
Dec 21, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 21, 2004ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2004REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 7, 2004CFITCASE FILE IN TICRS—
Jun 28, 2004EX3GSOU EXTENSION 3 GRANTED—
Jun 10, 2004EXT3SOU EXTENSION 3 FILED—
Jun 10, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 8, 2004EX2GSOU EXTENSION 2 GRANTED—
Jun 8, 2004PETGPETITION TO REVIVE-GRANTED—
Feb 26, 2004PETRPETITION TO REVIVE-RECEIVED—
Feb 26, 2004MAILPAPER RECEIVED—
Jan 7, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 24, 2003EXT2SOU EXTENSION 2 FILED—
Dec 10, 2003EX1GSOU EXTENSION 1 GRANTED—
Nov 24, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2003EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 24, 2003EXT1SOU EXTENSION 1 FILED—
Jun 18, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 24, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 1, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 11, 2002NPUBNOTICE OF PUBLICATION—
Jun 21, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 24, 2002MAILPAPER RECEIVED—
Mar 23, 2000CNSLLETTER OF SUSPENSION MAILED—
Dec 6, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 8, 1999DOCKASSIGNED TO EXAMINER—
Jun 1, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance